Skip to content

Feasibility research on the application of the QCT evaluation system in assessing ankle osteoporosis

Feasibility research on the application of the QCT evaluation system in assessing ankle osteoporosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096360
Enrollment
Unknown
Registered
2025-01-22
Start date
2025-01-27
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Observation group:None

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Postmenopausal women (at least 12 consecutive months without menstruation) or individuals aged 50 and above. 2.Individuals capable of undergoing ankle QCT and lumbar spine QCT, DXA scans, ensuring data comparability. 3.Voluntary participation in the study and signing of the informed consent form. 4.Patients eligible for laboratory tests (including liver, kidney, and blood function tests, blood calcium, blood phosphorus, alkaline phosphatase (ALP), parathyroid hormone (PTH), erythrocyte sedimentation rate (ESR), 25-hydroxyvitamin D, routine blood and urine tests, ß-collagen degradation products (ß-CTX), osteocalcin, serum creatinine, and cystatin C).

Exclusion criteria

Exclusion criteria: 1.Patients who have received osteoporosis treatment (such as bisphosphonates, estrogen, etc.) in the past two years and have continued treatment for more than 3 months. 2.Participants who cannot undergo stable scanning due to severe trauma or bone tumors in the spine or both feet. 3.Participants with a history of foot developmental abnormalities, severe trauma, or deformities that affect the normal structure of the ankle joint. 4.Participants with severe endocrine diseases (such as hyperparathyroidism) or those who have been on long-term medication affecting bone metabolism (such as hormonal drugs or anti-osteoporosis medications).

Design outcomes

Primary

MeasureTime frame
Ankle QCT bone mineral density;Lumbar spine QCT bone mineral density;

Secondary

MeasureTime frame
Sensitivity;Specificity;

Countries

China

Contacts

Public ContactWang Lei

Shanghai Sixth People's Hospital

wanglei0131@sjtu.edu.cn+86 189 3017 2609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026